Body fat distribution and adipokine secretion are not associated with diabetic retinopathy in patients with type 2 diabetes mellitus

Ophthalmic Research

Volumn 51, Issue 1, 2013, Pages 42-45

  Dossarps, D ^a   Petit, J M ^a   Guiu, B ^a   Cercueil, J P ^a   Duvillard, L ^a   Bron, A M ^a   Creuzot Garcher, C ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Adiponectin; Diabetic retinopathy; Leptin; Type 2 diabetes mellitus; Visceral fat

Indexed keywords

ADIPONECTIN; CREATININE; HEMOGLOBIN A1C; LEPTIN; TRIACYLGLYCEROL;

ABDOMINAL FAT; ADULT; AGED; BODY FAT DISTRIBUTION; CREATININE BLOOD LEVEL; CYTOKINE RELEASE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; INTRAABDOMINAL FAT; LIPID STORAGE; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SUBCUTANEOUS FAT; ARTICLE; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; BODY FAT DISTRIBUTION; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; LEPTIN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 84890028699     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000355323     Document Type: Review

References (26)

1. Frank RN: Diabetic retinopathy. N Engl J Med 2004; 350: 48-58.
2. Klein R, Klein BE, Moss SE: Visual impairment in diabetes. Ophthalmology 1984; 91: 1-9.
3. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-986.
4. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL: The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102: 520-526.
5. Boyko EJ, Fujimoto WY, Leonetti DL, Newell- Morris L: Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care 2000; 23: 465-471.
6. Gastaldelli A, Miyazaki Y, Pettiti M, Matsuda M, Mahankali S, Santini E, DeFronzo RA, Ferrannini E: Metabolic effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab 2002; 87: 5098-5103.
7. Raji A, Seely EW, Arky RA, Simonson DC: Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001; 86: 5366-5371.
8. Anan F, Masaki T, Ito Y, Eto T, Umeno Y, Eshima N, Saikawa T, Yoshimatsu H: Diabetic retinopathy is associated with visceral fat accumulation in Japanese type 2 diabetes mellitus patients. Metabolism 2010; 59: 314-319.
9. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, Polak BC: Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn study. Diabetes Care 2002; 25: 1320-1325.
10. Stefan N, Stumvoll M: Adiponectin - its role in metabolism and beyond. Horm Metab Res 2002; 34: 469-474.
11. Goldstein BJ, Scalia R: Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004; 89: 2563-2568.
12. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB: Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006; 8: 264-280.
13. Krenning G, Moonen JR, Harmsen MC: Pleiotropism of adiponectin: inflammation, neovascularization, and fibrosis. Circ Res 2009; 104: 1029-1031.
14. Higuchi A, Ohashi K, Kihara S, Walsh K, Ouchi N: Adiponectin suppresses pathological microvessel formation in retina through modulation of tumor necrosis factor-α expression. Circ Res 2009; 104: 1058-1065.
15. Ross R, Leger L, Morris D, de Guise J, Guardo R: Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol 1992; 72: 787-795.
16. Wilkinson CP, Ferris FL, 3rd, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT: Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110: 1677-1682.
17. Matsuda M, Kawasaki F, Yamada K, Kanda Y, Saito M, Eto M, Matsuki M, Kaku K: Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese type 2 diabetic subjects. Diabet Med 2004; 21: 881-888.
18. Yilmaz MI, Sonmez A, Acikel C, Celik T, Bingol N, Pinar M, Bayraktar Z, Ozata M: Adiponectin may play a part in the pathogenesis of diabetic retinopathy. Eur J Endocrinol 2004; 151: 135-140.
19. Kato K, Osawa H, Ochi M, Kusunoki Y, Ebisui O, Ohno K, Ohashi J, Shimizu I, Fujii Y, Tanimoto M, Makino H: Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy. Clin Endocrinol (Oxf) 2008; 68: 442-449.
20. Looker HC, Krakoff J, Funahashi T, Matsuzawa Y, Tanaka S, Nelson RG, Knowler WC, Lindsay RS, Hanson RL: Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 4010-4017.
21. Saraheimo M, Forsblom C, Fagerudd J, Teppo AM, Pettersson-Fernholm K, Frystyk J, Flyvbjerg A, Groop PH: Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care 2005; 28: 1410-1414.
22. Sari R, Balci MK, Apaydin C: The relationship between plasma leptin levels and chronic complication in patients with type 2 diabetes mellitus. Metab Syndr Relat Disord 2010; 8: 499-503.
23. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, Flores-Riveros JR: Biological action of leptin as an angiogenic factor. Science 1998; 281: 1683-1686.
24. Suganami E, Takagi H, Ohashi H, Suzuma K, Suzuma I, Oh H, Watanabe D, Ojima T, Suganami T, Fujio Y, Nakao K, Ogawa Y, Yoshimura N: Leptin stimulates ischemia-induced retinal neovascularization: possible role of vascular endothelial growth factor expressed in retinal endothelial cells. Diabetes 2004; 53: 2443-2448.
25. Tayama K, Inukai T, Shimomura Y: Preperitoneal fat deposition estimated by ultrasonography in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1999; 43: 49-58.
26. Rasouli N, Yao-Borengasser A, Miles LM, Elbein SC, Kern PA: Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression. Am J Physiol Endocrinol Metab 2006; 290:E42- E46.